Human Papilloma Virus Vaccine: Determinants of Acceptability by Mothers for Adolescents in Nigeria

Michael, C. Ezeanochie, Biodun N. Olagbuji

Abstract

Vaccination of adolescent females against Human Papilloma Virus (HPV), the causative agent for cervical cancer has recently become available. As minors, parental acceptance of the vaccines for adolescent daughters requires exploration. This was a crosssectional survey of 201 mothers attending the gynaecology clinic in a University Teaching Hospital in Nigeria on acceptability of the HPV vaccines and its determinants. Although 70% accepted vaccination of their daughters, 30% were unwilling and the commonest reason for unwillingness was that it may encourage sexual promiscuity (62.3%). Mothers with poor knowledge of STI were significantly more unwilling to accept HPV vaccines compared to those with average or good knowledge (p=0.002). Furthermore, perception of susceptibility to HPV infection by daughters was significantly associated with acceptance of the vaccines (p=0.0001). Increased advocacy and public enlightenment on cervical cancer control and the role of HPV vaccines in its prevention is still necessary especially in developing countries. (Afr J Reprod Health 2014; 18[3]: 154-158)

 

Keywords: Cervical cancer, Human papilloma virus, vaccine, Nigeria

  

Résumé 

La vaccination des adolescentes contre le virus du papillome humain (VPH), l'agent causal du cancer du col, vient récemment d’être  disponible. Comme les mineurs, l'acceptation parentale des vaccins pour les filles adolescentes nécessite l'exploration. Il s'agissait d'une étude transversale auprès de 201 mères qui fréquentent la clinique de gynécologie dans un Centre Hospitalier Universitaire  au Nigeria sur l'acceptabilité des vaccins contre le VPH et de ses déterminants. Bien que 70% aient  accepté la vaccination de leurs filles, 30% ont refusé et la raison la plus courante pour le refus était que cela peut encourager la promiscuité sexuelle (62,3%). Les mères qui ont une mauvaise connaissance des ISTs étaient, de façon significative,  plus disposés à ne pas accepter les vaccins HPV par rapport à celle qui ont une connaissance moyenne ou bonne (p = 0,002). En outre, la perception de la susceptibilité à l'infection par le VPH filles était significativement associée à l'acceptation des vaccins (p = 0,0001). Un plaidoyer accru et la sensibilisation du public sur le contrôle du cancer du col et le rôle des vaccins contre le VPH dans la prévention, est toujours nécessaire surtout dans les pays en développement. (Afr J Reprod Health 2014; 18[3]: 154-158)

 

Mots-clés: cancer du col utérin, virus du papillome humain, vaccins, Nigeria  

Full Text:

PDF

References

Fanta BE. The distribution of Human papilloma virus infection in women with cervical histological abnormalities from an area with high incidence of cervical cancer. Ethiop Med J. 2005; 43 (3):151-8

Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM.GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. Available from: http://globocan.iarc.fr, accessed on 27/12/2012.

Schiffman M, Castle P, Jeronimo J, Rodrigues A, Wacholder S. Human papilloma virus and cervical cancer. Lancet 2007; 370 (9590); 890-907

Langley CL, Benga-De E, Critchlow CW, Ndoye I, Mbengue-Ly MD, Kuypers J et al. HIV-1,HIV-2, human papilloma virus infection and cervical neoplasia in high risk. African women. AIDS; 1996; 10 (4): 413-7

Ruland R, Prugger C, Schiffer R, Requidor M, Lelle RJ. Prevalence of human papilloma virus infection in women in rural Ethiopia. Eur J Epidemiol. 2006; 21 (9) :727-9

Waller J, Marlow L, Wardle J. Mothers’ Attitude towards preventing cervical cancer through Human papiloma virus vaccination; A Qualitative study Cancer Epidemiol Biomarkens Prev 2006; 15(7) : 1257-61

Mays RM, Sturm LA, Zimet GD. Parental perspective on vaccinating children against sexually transmitted infections. Soc. Sci Med 2004; 58 (7):1405-13.

Norman AC, Petra J. Acceptance of HPV vaccination among Californians parents of daughters: A Representative state-wide analysis. Journal of Adolescent Health: 2007; 40: 108-115.

Dempsey AF, Zinnet GD, Davis RL, Koutsky L. Factors that are associated with parental acceptance of human papilloma virus vaccine: a randomized intervention study of written information that HPV. Paediatrics. 2006; 117(5): 1486 – 93.

Lazcano-Ponce E, Rivera L, Arillo-Santillan E, Salmeron J, Hernandez-Avila M, Munoz N. Acceptability of human papilloma virus vaccines (HPV) trial vaccine among mothers of adolescents in enernavaca, Mexico. Arch Med. Res 2001; 32(3): 243 – 7.

Zinnet GD, Perkins SM, Sturm LA, Bair RM, Juliar BE, Mays RM. Predictors of STI vaccine acceptability among parents and their adolescent children. J Adolesc Health 2005; 37(3): 179 – 86.

Davis K, Dickmann Ed, Ferris D, Dias JK. Human Papilloma virus vaccine acceptability among parents of 10 to 15 year old adolescents. J Low Genit Tract Dis 2004; 8: 188 – 94.

Zinnet GD, Lidelon N, Rosenthal SL et al. Psychosexual aspects of vaccine acceptability. Vaccine 2006; 24: 201 – 9.

Marlow LA, Waller J, Wardle J. Parental attitudes to prepubertal HPV vaccination. Vaccine 2007; 25(11): 1945 – 52.

Bochner CW, Howe SR, Berastein DS, et al. Viral sexually transmitted disease acceptability among college students. Sex Transm Dis 2003; 30: 774 – 8.

Dinh TA, Rosenthal SL, et al. Attitudes of mothers in Da Nang, Vietnam toward a human papilloma virus vaccine. J. Adolesc Health. 2007; 40(6): 559 – 63.

Katahoire RA, Jitta J, Kivumbi G, Murokora D, Arube WJ, Siu G et al. An assessment of the readiness for introduction of the HPV vaccine in Uganda. Afr J Reprod Health. 2008;12(3):159-72.

Refbacks

  • There are currently no refbacks.